MM

Mariana Mihalusova

Vice President at Venrock

San Francisco Bay Area

Overview 

Mariana Mihalusova is an experienced Investor and Drug Developer based in the San Francisco Bay Area. With a background in Molecular Biology and Biochemistry, she has held key leadership roles at top biotech companies like Celgene and currently serves as a Vice President at Venrock. Mariana's career highlights include her extensive experience in global project leadership within the pharmaceutical industry and her current role as a Board Member and Observer at multiple promising biotech startups.

Work Experience 

  • Board Observer

    2024 - Current

  • Board Observer

    2023

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Raised $91,000,000.00 from J. Wood Capital Advisors, Polaris Partners, Invus, Sanofi Ventures, Peter M. Hecht and Venrock.

  • Board Member

    2022

  • Board Observer

    2021

MBrace Therapeutics is a privately held biopharmaceutical business.

Raised $110,000,000.00 from Alta Partners, Cowen Healthcare Investments, Avidity Partners, Venrock and TPG.

  • Board Observer

    2020

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.

Raised $126,599,251.00 from Venrock Healthcare Capital Partners, Venrock, First Round Capital, Foresite Capital, OMX Ventures, Refactor, Perceptive Advisors, Highside Capital Management, Viking Global Investors and Lifeforce Capital.

  • Vice President

    2020

Venrock is a venture capital firm investing in technology and healthcare companies.

  • Executive Director, Global Project Leadership, Research & Early Development

    2017 - 2020

    Celgene was acquired by Bristol-Myers Squibb Company in Nov 2019. Led drug development efforts for 15 compounds (small molecules, biologics, engineered cell therapies) in hematology, oncology, inflammation/immunology, and neurodegenerative diseases. Responsible for the formulation and execution of global integrated development strategies, including scientific rationale, clinical development, budget, regulatory, and technical strategies. Managed large, cross-functional teams comprised of discovery, clinical, clinical operations, translational, regulatory, IP, commercial, CMC, toxicology, DMPK, clinical pharmacology, drug safety, medical affairs, and market access.

  • Senior Director, Global Project Leadership, Research & Early Development

    2015 - 2017

  • Director, Global Project Leadership, Research & Early Development

    2015 - 2015

  • Associate Director, Global Project Leadership

    2014 - 2015

  • Sr. Manager, Global Project Leadership

    2012 - 2014

  • Graduate Research Assistant / Teaching Fellow

    2004 - 2010

    Research areas: single-molecule/nanoscale imaging and analysis, telomerase structure and function Teaching Fellow: Molecular Pathophysiology and Pharmacology of Human Disease, Molecular Genetics of Neural Development and Behavior, and Molecular Biology.

Articles About Mariana

Relevant Websites